PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2012; 7(9): e43761.
Published online 2012 September 11. doi:  10.1371/journal.pone.0043761
PMCID: PMC3439487

Structure of a Novel Winged-Helix Like Domain from Human NFRKB Protein

Beata G. Vertessy, Editor

Abstract

The human nuclear factor related to kappa-B-binding protein (NFRKB) is a 1299-residue protein that is a component of the metazoan INO80 complex involved in chromatin remodeling, transcription regulation, DNA replication and DNA repair. Although full length NFRKB is predicted to be around 65% disordered, comparative sequence analysis identified several potentially structured sections in the N-terminal region of the protein. These regions were targeted for crystallographic studies, and the structure of one of these regions spanning residues 370–495 was determined using the JCSG high-throughput structure determination pipeline. The structure reveals a novel, mostly helical domain reminiscent of the winged-helix fold typically involved in DNA binding. However, further analysis shows that this domain does not bind DNA, suggesting it may belong to a small group of winged-helix domains involved in protein-protein interactions.

Introduction

The INO80 complex is a universally conserved multi-subunit protein complex anchored around the Snf2 family ATPase (INO80 protein), and is involved in several DNA-related functions including chromatin remodeling, transcription regulation, replication, and DNA repair [1][7]. The mammalian INO80 complex is composed of three protein modules [2], one of which consists of proteins specific to metazoa (animals), and not involved in ATP-dependent nucleosome remodeling. Nuclear factor related to kappa-B-binding protein (NFRKB) is a part of this module and modulates the deubiquitinase activity of UCHL5 in the INO80 complex [7]. Recent genome-wide RNAi screening revealed that NFRKB has an important function in the acquisition of pluripotency of human cells [8]. NFRKB enhances induced pluripotent stem cell generation and knockdown of the NFRKB gene affects the reprogramming process leading to a reduced number of human induced pluripotent stem (iPS) cell colonies.

The human NFKRB protein (Uniprot ID Q6P4R8), also known as subunit G of the INO80 complex, consists of 1299 amino acids. This subunit is responsible for DNA binding with a consensus sequence of 5′-GGGGAATCTCC-3′ [7]. The structure of the full-length NFRKB has yet to be determined, most likely due to the challenges of crystallizing such a large protein with numerous domains and predicted disordered regions. NFRKB is predicted to be 65% disordered, with the longest disordered segment (650aa) spanning the entire C-terminal half of the protein. However, at least three structured domains are predicted in the N-terminal half of NFRKB, and could be amenable to X-ray structural studies [9]. Based on PsiPred and Disopred sequence analyses, we made 16 constructs that covered various possible boundaries of these three putative domains, and one construct, residues 370–495, produced diffraction-quality crystals. The structure of this domain was determined to 2.18 Å resolution and reveals a novel helical domain (NFRKB_WHL) bearing remarkable similarity to a winged-helix domain, usually associated with DNA binding. Based on our structural findings, this domain was subsequently used to seed a new NFRKB winged-helix-like PFAM [10] family (PF14465).

Results and Discussion

Overall Structure

The crystal structure of the human NFRKB_WHL domain (residues 370–495) consists of two protomers (residues 372–483 in chain A and 370–483 in chain B), one sodium ion and 25 water molecules in the crystallographic asymmetric unit. The last 12 residues of the construct (residues 484–495) were disordered and were not modeled. In addition, residues 370–371, 463–465 in chain A and 440–443, 462–463 in chain B were not modeled due to poor electron density. The Matthews' coefficient (VM) [11] and the estimated solvent content are 1.84 Å3/Da and 33.1% respectively. The Ramachandran plot produced by MolProbity [12] shows that 97.5% of the residues are in favored regions with no outliers.

The NFRKB_WHL structure adopts a fold similar to the winged-helix DNA binding fold, comprising of four α-helices, three 310-helices and a short β-sheet composed of three β-strands (Figure 1).

Figure 1
Crystal structure of the winged-helix domain of human NFRKB.

Structural similarities to other DNA binding proteins

A search for structurally similar proteins using the DALI server [13] returned about 300 hits with Z-scores above 5.0, with a maximum score of only 7.5. Most of the matches were to DNA binding domains within large, multidomain, proteins, with a few low scoring matches to proteins involved in protein-protein interactions. The closest match was to the DNA binding domain of the virulence gene activator AphA protein from Vibrio cholerae (PDB code 1yg2 [14]) with a Z-score of 7.5 and RMSD of 3.0 Å over 67 residues. This structure, however, was determined without DNA and, therefore, does not provide any insights on the potential role of NFRKB _WHL in DNA binding.

Can NFRKB_WHL bind DNA?

In order to investigate whether NFRKB_WHL might interact with DNA, 45 of the top DALI hits that had bound DNA in their structures were superimposed onto the NFRKB_WHL structure to identify regions potentially involved in DNA binding (Figure 2). Further analysis of the superimposed structures revealed two types of DNA binding modes. The first group includes structures where the main recognition helix (α3 in NFRKB_WHL) binds in the major groove of the bound DNA (PDB codes 2d45, 1sax, 1u8r, 1xsd, 2xro, 3co7) (Figure 2). The second group includes structures with Z-DNA bound to proteins (PDB codes 1j75, 2gxb, 2heo, 3eyi) where there is limited interaction between protein and DNA (Figure 3).

Figure 2
Superposition of NFRKB_WHL domain structure with the MecI repressor structure from Staphylococcus aureus (PDB code 2d45).
Figure 3
Superposition of NFRKB_WHL domain onto the DNA-binding domain Zα of DLM-1 (PDB code: 1j75).

In both cases, however, the residues interacting with DNA are not conserved in NFRKB_WHL. A structure-based sequence alignment of helix α3 shows a clear lack of conserved residues (Figure 4), with the exception of two hydrophobic residues that point toward the hydrophobic core of the protein and are likely involved in stabilizing the interaction and orientation of this helix on the protein. The sequence of this helix lacks any basic residues, thereby making it unlikely to interact with DNA. Therefore, despite the structural similarity to winged-helix DNA binding domains, NFRKB_WHL is unlikely to bind DNA. The calculated isoelectric point of 4.3 of this domain is also not favorable for DNA binding. In addition, results of Differential Scanning Fluorimetry (DSF) experiments to test whether there is any change in stability of NFRKB_WHL in the presence of consensus DNA (5′-GGGGAATCTCC-3′) further support the observation that NFRKB_WHL may not bind DNA. The protein's melting temperature remains unchanged upon mixing with DNA for different ratios of protein:DNA (Figure 5, Table 1), indicating that the DNA tested does not stabilize NFRKB_WHL.

Figure 4
Structure-based sequence alignment of helix α3.
Figure 5
Lack of DNA binding to the NFRKB winged helix domain.
Table 1
Effect of DNA on the thermal unfolding of the NFRKB winged helix domain.

Protein-protein interaction

Interestingly, one of the higher scoring structural matches identified in the DALI search is a winged-helix domain from the yeast (PDB code 1ldd) and human (PDB code 1ldj) anaphase-promoting complex. NFRKB_WHL has a significant structural similarity (Dali Z-score of 6.7) to one of the winged-helix motifs within the C-terminal domain (CTD) of the cullin protein portion of the of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex. This domain follows three repeats of the cullin repeat and is involved in binding of the RING finger protein Rbx1 [15]. NFRKB_WHL and the winged-helix subdomain of CTD superpose with a RMSD of 2.15 Å over 63 residues (Figure 6) and share a sequence identity of 10%. Thus, it is possible that NFRKB_WHL may be involved in protein-protein interactions rather than DNA binding.

Figure 6
Comparison of NFRKB_WHL domain with the Cul1 domain of the yeast anaphase-promoting complex.

New PFAM domain

Initial sequence analysis of this domain, including a sequence search of the PFAM database [10], did not identify any similarity to other winged-helix DNA binding domains. In fact, none of the fold prediction or distant homology recognition tools yielded any statistically significant matches to any characterized protein family. Thus, the NFRKB_WHL structure formed the basis for a new Pfam domain, PF14465. This new domain was thereafter identified in all animal genomes, as well as several single cell eukaryotes. It is always found in proteins bearing overall homology to NFRKB.

Conclusion

We have determined the structure of a predicted ordered domain from the human NFRKB protein at 2.18 Å resolution. The identification of this domain was based on PsiPred and Disopred sequence analysis that indicated the existence of a structurally ordered region bordered by disordered/low complexity regions. The crystal structure of this domain unexpectedly revealed similarity to winged-helix DNA binding domains in structures, such as MecI repressor (PDB code 2d45; [16]) and Zα domain of DLM-1 (PDB code 1j75; [17]). However, the lack of sequence similarity between this domain and other winged-helix DNA binding domains, the absence of any observable protein-DNA interaction in a DSF experiment, and the lack of positively charged residues in the putative DNA binding helix α3, indicate that this domain likely does not bind DNA. However, similarity to the C-terminal domain in cullins, which is involved in binding of other members of the Skp, Cullin, F-box containing (SCF) complex, suggest a possible role in protein-protein interactions. The NFRKB_WHL domain is the founding member of a new Pfam winged-helix-like family, (NFRKB_winged; PF14465; http://pfam.sanger.ac.uk/family/PF14465), which currently contains 39 sequences from 33 species.

Materials and Methods

Domain prediction and construct design

The protein encoded by the human NFRKB gene (Uniprot id: Q6P4R8) did not have any domain annotation in the PfamA database (release 25.0) [10], and fold recognition algorithms (HHPred [18] and FFAS [19]) did not yield any significant domain predictions. However, secondary structure and structural disorder predictions calculated with PsiPred [20] and Disopred [21], respectively, suggested that the N-terminal half of this protein likely contained up to three domains with well-defined, three-dimensional structure. Since these predictions in general do not provide reliable domain boundaries, 16 constructs corresponding to predicted ordered regions were selected (1–208, 1–225, 1–275, 1–307, 1–486, 1–495, 1–651, 1–710, 335–495, 335–585, 357–485, 366–485, 370–495, 370–585, 503–651, 503–710) for expression and crystallization trials. The construct consisting of residues 370–495 yielded diffracting crystals.

Cloning, expression, purification, crystallization

Clones were generated using the Polymerase Incomplete Primer Extension (PIPE) cloning method [22]. The gene encoding RF2003A.NFRKB (UniProt: Q6P4R8) was amplified by polymerase chain reaction (PCR) using a Homo sapiens cDNA from the Mammalian Gene Collection (MGC) as template, PfuTurbo DNA polymerase (Stratagene) and I-PIPE (Insert) primers (forward primer, 5′-ctgtacttccagggcCTTGGAATCAATGAAATATCTTCCAGC -3′; reverse primer, 5′-aattaagtcgcgttaTGAGCTGTCTTCATTTTCTTGCTTACAG-3′, target sequence in upper case) that included sequences for the predicted 5′ and 3′ ends of the full length construct. The expression vector, pSpeedET, which encodes an amino-terminal tobacco etch virus (TEV) protease-cleavable expression and purification tag (MGSDKIHHHHHHENLYFQ/G), was PCR amplified with V-PIPE (Vector) primers (forward primer: 5′-taacgcgacttaattaactcgtttaaacggtctccagc-3′, reverse primer: 5′-gccctggaagtacaggttttcgtgatgatgatgatgatg-3′). V-PIPE and I-PIPE PCR products were mixed to anneal the amplified DNA fragments together. Escherichia coli GeneHogs (Invitrogen) competent cells were transformed with the I-PIPE/V-PIPE mixture and dispensed on selective LB-agar plates. The cloning junctions were confirmed by DNA sequencing. Using the PIPE method, the gene segment encoding residues M1-C369 and D496-Q1299 were deleted. Expression was performed in a selenomethionine-containing medium at 37°C. Selenomethionine was incorporated via inhibition of methionine biosynthesis [23], which does not require a methionine auxotrophic strain. At the end of fermentation, lysozyme was added to the culture to a final concentration of 250 µg/ml, and the cells were harvested and frozen. After one freeze/thaw cycle, the cells were homogenized and sonicated in lysis buffer [40 mM Tris, 300 mM NaCl, 10 mM imidazole, 1 mM Tris(2-carboxyethyl)phosphine-HCl (TCEP), pH 8.0]. The lysate was clarified by centrifugation at 32,500× g for 30 minutes. The soluble fraction was passed over nickel-chelating resin (GE Healthcare) pre-equilibrated with lysis buffer, the resin washed with wash buffer [40 mM Tris, 300 mM NaCl, 40 mM imidazole, 10% (v/v) glycerol, 1 mM TCEP, pH 8.0], and the protein was eluted with elution buffer [20 mM Tris, 300 mM imidazole, 10% (v/v) glycerol, 150 mM NaCl, 1 mM TCEP, pH 8.0]. The eluate was buffer-exchanged with TEV buffer [20 mM Tris, 150 mM NaCl, 30 mM imidazole, 1 mM TCEP, pH 8.0] using a PD-10 column (GE Healthcare), and incubated with 1 mg of TEV protease per 15 mg of eluted protein for 2 hr at ambient temperature followed by overnight incubation at 4°C. The protease-treated eluate was passed over nickel-chelating resin (GE Healthcare) pre-equilibrated with crystallization buffer [20 mM Tris, 150 mM NaCl, 30 mM imidazole, 1 mM TCEP, pH 8.0] and the resin was washed with the same buffer. The flow-through and wash fractions were combined and concentrated to 21.3 mg/ml by centrifugal ultrafiltration (Millipore) for crystallization trials. Lysine residues were reductively methylated by adding 40 µl 0.98 M dimethylaminoborane and 80 µl 3.26% by weight formaldehyde, per milliliter of protein, over 2 hours in the presence of crystallization buffer at 277 K [24]. Methylation reagents were subsequently removed using a PD-10 column and the protein was concentrated to 26.7 mg/ml using ultrafiltration. The NFRKB_WHL construct was crystallized using the nanodroplet vapor diffusion method [25] with standard JCSG crystallization protocols [26]. Sitting drops composed of 100 nl protein solution mixed with 100 nl crystallization solution were equilibrated against a 50 µl reservoir at 277 K for 22 days prior to harvest. The crystallization solution consisted of 0.09 M HEPES pH 7.5, 10% glycerol, 1.26 M tri-sodium citrate. Ethylene glycol was added to a final concentration of 10% (v/v) as a cryoprotectant. Initial screening for diffraction was carried out using the Stanford Automated Mounting system (SAM) [27] at the Stanford Synchrotron Radiation Lightsource (SSRL, Menlo Park, CA). The complementary DNA from Homo sapiens (MGC Number 71524) was obtained from Invitrogen (Mammalian Gene Collection).

Data collection, structure solution, refinement

Multi-wavelength anomalous diffraction (MAD) data were collected to 2.18 Å resolution at wavelengths corresponding to inflection (0.97936 Å), peak (0.97915 Å), and high energy remote (0.91837 Å) of the Selenium edge at beam line BL9-2 at SSRL. The data sets were collected at −173°C using a MAR325 CCD detector and the BLU-ICE data collection environment [28]. The data were processed with XDS [29] and scaled with XSCALE [30] in space group P43212. Phasing was performed with SHELXD [31] and autoSHARP [32] which resulted in a mean figure of merit of 0.18 with one selenium site per protein chain. Automatic model building was performed with RESOLVE [33]. Model completion and refinement were performed with COOT [34] and REFMAC 5.6.0116 [35] using the high energy remote wavelength data. The refinement included experimental phase restraints in the form of Hendrickson-Lattman coefficients from SHARP, NCS restraints, and TLS refinement with two TLS groups per chain. Data collection and refinement statistics are summarized in Table 2.

Table 2
Crystallographic data and refinement statistics for NFRKB (PDB code 3u21).

DNA Binding

The Differential Scanning Fluorimetry (DSF) experiment used to measure the effect of DNA binding on protein stability was performed at room temperature using a MxPro3005P PCR instrument (Stratagene). The optimized reaction mixture contained 10 µM of NFRKB (aa 370–495), 20 µM, 80 µM or 160 µM DNA (GGGGAATCTCC; the consensus sequence for human NFRKB, Uniprot Id Q6P4R8) and 1× SYPRO Orange protein gel stain (Invitrogen) in the assay buffer (20 mM Tris-HCl pH 8.0, 10% glycerol, 5 mM DTT, 150 mM NaCl). The DNA oligonucleotides were purchased from Integrated DNA technologies. Each experiment was performed in triplicate in 96 well polypropylene plates (Agilent Technologies) by adding 20 µl of protein/DNA mixture to 30 µl of dye/buffer mixture. The reactions were mixed, centrifuged and incubated for 30 min at 4°C. For thermal stability measurements of the protein, the fluorescence of the dye was followed as a function of time using a FRROX filter set with an excitation wavelength of 492 nm and an emission wavelength of 610 nm. Data were collected from 25° to 95°C at 1°C/30 s intervals, and plotted to calculate the melting temperature of the protein (Figure 5, Table 1).

Validation and deposition

The quality of the crystal structure was analyzed using the JCSG Quality Control server (http://smb.slac.stanford.edu/jcsg/QC/). This server verifies the stereochemical quality of the model using AutoDepInputTool [36], MolProbity [12], WHATIF [37], RESOLVE [33], as well as several in-house scripts, and summarizes the outputs. Protein quaternary structure analysis was carried out using the PISA server [38]. Figures were prepared with PyMOL [39]. Atomic coordinates and experimental structure factors have been deposited in the PDB and are accessible under the code 3u21.

Acknowledgments

We thank the members of the JCSG high-throughput structural biology pipeline for their contribution to this work. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The contents of this publication are solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences, the National Center for Research Resources, or the National Institutes of Health.

Funding Statement

This work was supported by the National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative grants U01 GM094614 to Robert Fletterick and U54 GM094586 to the Joint Center for Structural Genomics (JCSG). The Stanford Synchrotron Radiation Lightsource (SSRL) Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Bao Y, Shen X (2007) INO80 subfamily of chromatin remodeling complexes. Mutat Res 618: 18–29. [PMC free article] [PubMed]
2. Chen L, Cai Y, Jin J, Florens L, Swanson SK, et al. (2011) Subunit organization of the human INO80 chromatin remodeling complex: an evolutionarily conserved core complex catalyzes ATP-dependent nucleosome remodeling. J Biol Chem 286: 11283–11289. [PubMed]
3. Conaway RC, Conaway JW (2009) The INO80 chromatin remodeling complex in transcription, replication and repair. Trends Biochem Sci 34: 71–77. [PubMed]
4. Ebbert R, Birkmann A, Schuller HJ (1999) The product of the SNF2/SWI2 paralogue INO80 of Saccharomyces cerevisiae required for efficient expression of various yeast structural genes is part of a high-molecular-weight protein complex. Mol Microbiol 32: 741–751. [PubMed]
5. Jin J, Cai Y, Yao T, Gottschalk AJ, Florens L, et al. (2005) A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex. J Biol Chem 280: 41207–41212. [PubMed]
6. Shen X, Mizuguchi G, Hamiche A, Wu C (2000) A chromatin remodelling complex involved in transcription and DNA processing. Nature 406: 541–544. [PubMed]
7. Yao T, Song L, Jin J, Cai Y, Takahashi H, et al. (2008) Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex. Mol Cell 31: 909–917. [PMC free article] [PubMed]
8. Chia NY, Chan YS, Feng B, Lu X, Orlov YL, et al. (2010) A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468: 316–320. [PubMed]
9. Slabinski L, Jaroszewski L, Rychlewski L, Wilson IA, Lesley SA, et al. (2007) XtalPred: a web server for prediction of protein crystallizability. Bioinformatics 23: 3403–3405. [PubMed]
10. Finn RD, Mistry J, Tate J, Coggill P, Heger A, et al. (2010) The Pfam protein families database. Nucleic Acids Res 38: D211–222. [PMC free article] [PubMed]
11. Matthews BW (1968) Solvent content of protein crystals. J Mol Biol 33: 491–497. [PubMed]
12. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35: W375–383. [PMC free article] [PubMed]
13. Holm L, Sander C (1995) Dali: a network tool for protein structure comparison. Trends Biochem Sci 20: 478–480. [PubMed]
14. De Silva RS, Kovacikova G, Lin W, Taylor RK, Skorupski K, et al. (2005) Crystal structure of the virulence gene activator AphA from Vibrio cholerae reveals it is a novel member of the winged helix transcription factor superfamily. J Biol Chem 280: 13779–13783. [PMC free article] [PubMed]
15. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, et al. (2002) Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416: 703–709. [PubMed]
16. Safo MK, Ko TP, Musayev FN, Zhao Q, Wang AH, et al. (2006) Structure of the MecI repressor from Staphylococcus aureus in complex with the cognate DNA operator of mec. Acta Crystallogr Sect F Struct Biol Cryst Commun 62: 320–324. [PMC free article] [PubMed]
17. Schwartz T, Behlke J, Lowenhaupt K, Heinemann U, Rich A (2001) Structure of the DLM-1-Z-DNA complex reveals a conserved family of Z-DNA-binding proteins. Nat Struct Biol 8: 761–765. [PubMed]
18. Rychlewski L, Jaroszewski L, Li W, Godzik A (2000) Comparison of sequence profiles. Strategies for structural predictions using sequence information. Protein Sci 9: 232–241. [PubMed]
19. Yang Y, Faraggi E, Zhao H, Zhou Y (2011) Improving protein fold recognition and template-based modeling by employing probabilistic-based matching between predicted one-dimensional structural properties of query and corresponding native properties of templates. Bioinformatics 27: 2076–2082. [PMC free article] [PubMed]
20. Bryson K, McGuffin LJ, Marsden RL, Ward JJ, Sodhi JS, et al. (2005) Protein structure prediction servers at University College London. Nucleic Acids Res 33: W36–38. [PMC free article] [PubMed]
21. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT (2004) Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol 337: 635–645. [PubMed]
22. Klock HE, Koesema EJ, Knuth MW, Lesley SA (2008) Combining the polymerase incomplete primer extension method for cloning and mutagenesis with microscreening to accelerate structural genomics efforts. Proteins 71: 982–994. [PubMed]
23. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J (1993) Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol 229: 105–124. [PubMed]
24. Walter TS, Meier C, Assenberg R, Au KF, Ren J, et al. (2006) Lysine methylation as a routine rescue strategy for protein crystallization. Structure 14: 1617–1622. [PubMed]
25. Santarsiero BD, Yegian DT, Lee CC, Spraggon G, Gu J, et al. (2002) An approach to rapid protein crystallization using nanodroplets. J Appl Crystallogr 35: 278–281.
26. Lesley SA, Kuhn P, Godzik A, Deacon AM, Mathews I, et al. (2002) Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A 99: 11664–11669. [PubMed]
27. Cohen AE, Ellis PJ, M.D. M, Deacon AM, Phizackerley RP (2002) An automated system to mount cryo-cooled protein crystals on a synchrotron beamline, using compact sample cassettes and a small-scale robot. J Appl Crystallogr 35: 720–726.
28. McPhillips TM, McPhillips SE, Chiu HJ, Cohen AE, Deacon AM, et al. (2002) Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines. J Synchrotron Radiat 9: 401–406. [PubMed]
29. Kabsch W (2010) Xds. Acta Crystallogr Sect D Biol Crystallogr 66: 125–132. [PMC free article] [PubMed]
30. Kabsch W (2010) Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr Sect D Biol Crystallogr 66: 133–144. [PMC free article] [PubMed]
31. Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr Sect A Found Crystallogr 64: 112–122. [PubMed]
32. Vonrhein C, Blanc E, Roversi P, Bricogne G (2007) Automated structure solution with autoSHARP. Methods Mol Biol 364: 215–230. [PubMed]
33. Terwilliger TC (2003) Improving macromolecular atomic models at moderate resolution by automated iterative model building, statistical density modification and refinement. Acta Crystallogr Sect D Biol Crystallogr 59: 1174–1182. [PMC free article] [PubMed]
34. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr Sect D Biol Crystallogr 66: 486–501. [PMC free article] [PubMed]
35. Winn MD, Murshudov GN, Papiz MZ (2003) Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol 374: 300–321. [PubMed]
36. Yang H, Guranovic V, Dutta S, Feng Z, Berman HM, et al. (2004) Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank. Acta Crystallogr Sect D Biol Crystallogr 60: 1833–1839. [PubMed]
37. Vriend G (1990) WHAT IF: a molecular modeling and drug design program. J Mol Graph 8: 52–56, 29. [PubMed]
38. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774–797. [PubMed]
39. Schrodinger LLC (2010) The PyMOL Molecular Graphics System, Version 1.3r1.
40. Gouet P, Courcelle E, Stuart DI, Metoz F (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305–308. [PubMed]
41. Diederichs K, Karplus PA (1997) Improved R-factors for diffraction data analysis in macromolecular crystallography. Nat Struct Biol 4: 269–275. [PubMed]
42. Collaborative Computational Project Number 4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr Sect D Biol Crystallogr 50: 760–763. [PubMed]
43. Cruickshank DW (1999) Remarks about protein structure precision. Acta Crystallogr Sect D Biol Crystallogr 55: 583–601. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science